AbioCor Implantable Replacement Heart
NCT00669357 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2013-05-03
Summary
Abiocor is a post market approval study for an Implantable Replacement Heart. This post approval study is currently on hold.
Conditions
- Severe Biventricular End Stage Heart Disease
Interventions
- DEVICE
-
Abiocor Implantable Replacement Heart
Replacement of heart
Sponsors & Collaborators
-
Abiomed Inc.
lead INDUSTRY
Eligibility
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
CoreValve VIVA Study Evaluation of the Clinical Outcomes of CoreValve in Degenerative Surgical Aortic Bioprosthesis.
NCT02209298 ·Status: COMPLETED
-
Confirmation Trial of the Acorn CorCap Cardiac Support Device (CSD) at the Same Time as Mitral Valve Repair
NCT00630266 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
NCT01240902 ·Status: COMPLETED ·Phase: NA
-
DuoCor Ventricular Assist System Early Feasibility Study
NCT06878508 ·Status: COMPLETED ·Phase: NA
-
InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Registry
NCT00273182 ·Status: COMPLETED
-
Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapical DS)
NCT02515539 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve
NCT00630916 ·Status: COMPLETED ·Phase: NA
-
MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing
NCT02006069 ·Status: TERMINATED ·Phase: NA
-
Medtronic Evolut™ EXPAND TAVR I Feasibility Study
NCT04639258 ·Status: TERMINATED ·Phase: NA
-
SyncAV Post-Market Trial
NCT04100148 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Conveyor Study
NCT03893578 ·Status: UNKNOWN ·Phase: NA
-
Mitroflow DL Post Approval Study- North America
NCT02351726 ·Status: TERMINATED ·Phase: NA
-
DuoCor 2 DOMINATE Study
NCT07233876 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A First in Human Study for the Versa Device for Tricuspid Regurgitation
NCT06368401 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Performance of the AccuCinch® System
NCT02624960 ·Status: WITHDRAWN ·Phase: NA
-
ChordArt System for Mitral Regurgitation
NCT03581656 ·Status: UNKNOWN ·Phase: NA
-
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
NCT01757665 ·Status: COMPLETED ·Phase: NA
-
Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function
NCT02153892 ·Status: COMPLETED ·Phase: NA
-
CORolla™ TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction
NCT01956526 ·Status: UNKNOWN ·Phase: NA
-
REDUCE LAP-HF III Corvia Protocol 1701
NCT03191656 ·Status: ACTIVE_NOT_RECRUITING
-
ImCardia for DHF to Treat Diastolic Heart Failure (DHF) Patient a Pilot Study
NCT01347125 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)
NCT02478008 ·Status: TERMINATED ·Phase: NA
-
Feasibility Study of a Percutaneous Mitral Valve Repair System.
NCT00209339 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Medtronic TAVR 2.0 US Clinical Study
NCT02738853 ·Status: COMPLETED ·Phase: NA
-
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
NCT00512005 ·Status: UNKNOWN ·Phase: PHASE1